← Back to all trials
Completed
NCT05412303
Vaso-inotropic Score and ECMO-VA Support in Post-cardiotomy Cardiogenic Shock.
Conditions: EMCO-VA
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 2769
Sponsor: Centre Hospitalier Universitaire Dijon
Location: Chu Dijon Bourogne Dijon
Summary
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a well-established lifesaving treatment for refractory cardiogenic shock, with or without concomitant respiratory failure. VA-ECMO is usually started in presence of refractory low cardiac output syndrome following CPB weaning. Currently, there is no consensus about the best timing for implantation and initiation of VA-ECMO in this setting. Some publications have suggested that VIS score could be used to determine the necessity of VA-ECMO in cardiologic area. It was demonstrated that a VIS score between 20 and 40 may be a cut-off value to discuss the implantation of VA-ECMO. Post cardiotomy shock is a very interesting setting because the timing of cardiogenic shock is known and several bias are more controlled than in medical area.
Based on the well-established ability of VIS Score in predicting mortality, we will investigate the role of the VIS Score as a determinant for early VA-ECMO implantation in patients suffering of post-cardiotomy cardiogenic shock.
Eligibility Criteria
Inclusion Criteria:
* age over 18 years
* Cardiac surgery with cardiopulmonary bypass
* Post cardiotomy cardiogenic shock
* ECMO-VA implanted in OR
Exclusion Criteria:
* LVAD
* Heart transplantation
* Incomplete data in relation to outcomes
* Cardiac arrest
Source: ClinicalTrials.gov (NCT05412303). StuddyBuddy aggregates publicly available trial information.